Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (Hepatitis C)

Details for Australian Patent Application No. 2003202347 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Llinas-Brunet, Montse; Gorys, Vida J

Agent Davies Collison Cave

Pub. Number AU-B-2003202347

PCT Number PCT/CA03/00090

PCT Pub. Number WO2003/064456

Priority 2,370,396 01.02.02 CA

Filing date 24 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 30 October 2008

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/7056 (2006.01)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/43 (2006.01) Medicinal preparations containing peptides - Enzymes

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/083 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/087 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 2,370,396 01.02.02 CA

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003202347

30 October 2008 Application Accepted

  Published as AU-B-2003202347

26 February 2009 Standard Patent Sealed

18 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003202348-Heterocyclic tripeptides as hepatitis c inhibitors

2003202346-MACROCYCLIC PEPTIDES ACTIVE AGAINST THE HEPATITIS C VIRUS